Works by Zhang, Dong‐Kun

Results: 3
    1

    High SHP2 expression determines the efficacy of PD‐1/PD‐L1 inhibitors in advanced KRAS mutant non‐small cell lung cancer.

    Published in:
    Thoracic Cancer, 2021, v. 12, n. 19, p. 2564, doi. 10.1111/1759-7714.14137
    By:
    • Feng, Hui‐Bo;
    • Chen, Yu;
    • Xie, Zhi;
    • Jiang, Jie;
    • Zhong, Yu‐Min;
    • Guo, Wei‐Bang;
    • Yan, Wen‐Qing;
    • Lv, Zhi‐Yi;
    • Lu, Dan‐Xia;
    • Liang, Hong‐Ling;
    • Xu, Fang‐Ping;
    • Yang, Jin‐Ji;
    • Yang, Xue‐Ning;
    • Zhou, Qing;
    • Zhang, Dong‐Kun;
    • Zhang, Zhou;
    • Chuai, Shao‐Kun;
    • Zhang, Heng‐Hui;
    • Wu, Yi‐Long;
    • Zhang, Xu‐Chao
    Publication type:
    Article
    2
    3

    Plasma EBV quantification is associated with the efficacy of immune checkpoint blockade and disease monitoring in patients with primary pulmonary lymphoepithelioma‐like carcinoma.

    Published in:
    Clinical & Translational Immunology, 2024, v. 13, n. 6, p. 1, doi. 10.1002/cti2.1515
    By:
    • Zhong, Yu‐Min;
    • Chen, Ji;
    • Jiang, Jie;
    • Zhou, Wen‐Bin;
    • Gao, Ling‐Ling;
    • Zhang, Shui‐Lian;
    • Yan, Wen‐Qing;
    • Chen, Yu;
    • Zhang, Dong‐Kun;
    • Lu, Dan‐Xia;
    • Lv, Zhi‐Yi;
    • Xie, Zhi;
    • Huang, Ying;
    • Guo, Wei‐Bang;
    • Wang, Bin‐Chao;
    • Yang, Jin‐Ji;
    • Yang, Xue‐Ning;
    • Wu, Yi‐Long;
    • Zhang, Xu‐Chao
    Publication type:
    Article